<DOC>
	<DOCNO>NCT01942369</DOCNO>
	<brief_summary>The purpose study describe change intensity specific endometriosis symptom baseline pre-surgery surgery subsequent continuous Diphereline ( Triptorelin Acetate ) treatment 24 week .</brief_summary>
	<brief_title>A Study Describe Efficacy Diphereline Following Conservative Surgery Deep Infiltrating Endometriosis ( DIE ) Patients Over Period 24 Months</brief_title>
	<detailed_description />
	<mesh_term>Endometriosis</mesh_term>
	<mesh_term>Triptorelin Pamoate</mesh_term>
	<criteria>Patients diagnose DIE receive surgery treatment within one month inclusion Premenopausal woman age &gt; =18 year old . Patient treat physician already make decision treat Diphereline . Patient mentally physically able express symptom complaint answer question . Pregnancy lactation . Patients currently treatment therapy GnRHa last 6 month . Premenopausal woman may reach menopause within 3 year post randomisation . Hypersensitivity Triptorelin one excipients Triptorelin 3.75mg Treatment another research drug last 3 month study Potentially unreliable patient , judge investigator unsuitable study .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Endometriosis</keyword>
</DOC>